KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) EBT (2016 - 2025)

Medpace Holdings' EBT history spans 11 years, with the latest figure at $156.8 million for Q4 2025.

  • For Q4 2025, EBT rose 17.14% year-over-year to $156.8 million; the TTM value through Dec 2025 reached $542.4 million, up 13.96%, while the annual FY2025 figure was $542.4 million, 13.96% up from the prior year.
  • EBT reached $156.8 million in Q4 2025 per MEDP's latest filing, up from $142.8 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $156.8 million in Q4 2025 to a low of $42.7 million in Q2 2021.
  • Average EBT over 5 years is $91.9 million, with a median of $84.6 million recorded in 2023.
  • Peak YoY movement for EBT: soared 49.61% in 2022, then grew 1.6% in 2023.
  • A 5-year view of EBT shows it stood at $55.9 million in 2021, then surged by 31.69% to $73.6 million in 2022, then grew by 23.17% to $90.7 million in 2023, then soared by 47.6% to $133.9 million in 2024, then rose by 17.14% to $156.8 million in 2025.
  • Per Business Quant, the three most recent readings for MEDP's EBT are $156.8 million (Q4 2025), $142.8 million (Q3 2025), and $124.5 million (Q2 2025).